YOUR TASKS AND RESPONSIBILITIES

The primary responsibilities of this role, Senior Director Global Biomarker Leader, are to: 

• Be a biomarker project leader (BPL) for one or more development programs and resume in this role strategic, clinical, scientific, technical and budgetary planning for the assigned biomarker projects;
• Act as an equal member of the Global Program Team (GPT), when required and provide relevant Oncology expertise to GPT when evaluating and developing translation and biomarker strategies;
• Act as thought partner to ER leaders, proactively following early projects prior to D2 and taking an active role from D2 onwards,assembling resources for subsequent biomarker activities on the project;
• Draw on resources from across the organization, particularly theTRGs, to ensure delivery of appropriate biomarker strategy;
• Ensure coordination of all aspects of biomarker delivery insynchronization with the drug R&D process, informed by deepunderstanding of clinical development in Oncology and state-of-the-art biomarker use in Oncology;
• Own, source and develop distinctive biomarker knowledge to support Bayer differentiation strategy, when necessary;
• Define, communicate and execute on the biomarker strategy foreach development program where he/she is BPL;
• Represent biomarker related aspects internally and externally in meetings with authorities and ethics committees, and with external key opinion leaders;
• Build and maintain network with academic institutions/diagnostic companies in Oncology;
• Work closely with ECL to ensure translation strategy has maximum success rate supported by a developable biomarker;
• Lead via internal and external collaborations the development ofbiomarkers and/or segmentation tools for internal decision making and/or as intended part of the product definition, whether to measure response (to aid dose finding or as surrogate endpoint) or to identify patient segments;
• Ensure regulatory compliance of biomarker activities and drivebiomarker qualification processes;
• Lead the global CS team and independently create, update and implement the Clinical Science (CS) development plan, presents it on internal decision-making committees, represent CS in global project teams and coordinate the preparation and submission of the CS dossier (this will apply if the candidate is nominated as Clinical Pharmacology Leader or Early Clinical Leader);
• Independently analyze, interpret and present results frombiomarker analyses and draw scientifically valid conclusions that support and enable decision making.

WHO YOU ARE

Your success will be driven by your demonstration of our LIFE values.  More specifically related to this position, Bayer seeks an incumbent who possesses the following:

Required Qualifications:

• Medical doctor (MD) and/or Ph.D. in Biochemistry, Molecular Biology or Genetics;
• Proven track record of research and/or clinical development in Oncology, including at least eight years of industry experience; thorough understanding of pathophysiology’s and therapies in oncology;
• Focus on translational sciences (cf., Proof of Concept) and/or biomarkers (including patient stratification for personalized medicine), and experience with regulatory framework for biosampling, biomarkers, translational medicine in Oncology;
• Outstanding scientific reputation as evidenced by multiple publications in peer reviewed journals and as speaker of conferences;
• Strong network in the academic and clinical community of Oncology;
• Strong leadership skills;
• Comfortable to marshal resources from different parts of the organization in the absence of formal reporting lines;
• Excellent interpersonal and communication skills (fluency in English, oral and written);
• Confident team player, assertive but willing to listen and to seek and learn from the views of others;
• Strategic influencing skills with experience in stakeholder management at leadership team level;
• Able to set and communicate a strategic vision.